Gerresheimer AG is the global go-to partner for medicine packaging, drug delivery devices and solutions with the broadest product range for pharma, health, well-being and biotech.

They bring every kind of medicine safely, reliably and conveniently to or into the patient. Customers and partners from all over the world approach them with new challenges.

They are their solution provider with the absolute will to deliver, from the concept up to the final product.
This is how Gerresheimer meets the needs of our customers and their customers – the users.

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

5AM’s investment professionals possess strong scientific, medical, operational, legal and finance expertise.

Sanofi is dedicated to supporting people through their health challenges. Sanofi is a global biopharmaceutical company focused on human health. Sanofi prevents illness with vaccines and provides innovative treatments to fight pain and ease suffering.

Sanofi stands by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

PBJ Capital is an independent venture firm investing in early stage technology companies.  PBJ looks for passionate and driven founders with innovative and disruptive ideas.  They invest $1 - $5 million in Seed- and Series A-stage companies, and they reserve capital in every deal to help their partner companies grow.

Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines.

Takeda focuses its R&D efforts on oncology, gastroenterology and central nervous system therapeutic areas plus vaccines.

Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. New innovative products, especially in oncology and gastroenterology, as well as our presence in Emerging Markets, fuel the growth of Takeda.

More than 30,000 Takeda employees are committed to improving quality of life for patients, and working with partners in health care in more than 70 countries.